Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹201 Cr
Revenue (TTM)
₹202 Cr
Net Profit (TTM)
₹11 Cr
ROE
3.6 %
ROCE
5.2 %
P/E Ratio
18.2
P/B Ratio
1.3
Industry P/E
26.59
EV/EBITDA
9
Div. Yield
0 %
Debt to Equity
0.3
Book Value
₹19.7
EPS
₹1.7
Face value
10
Shares outstanding
76,633,296
CFO
₹-58.89 Cr
EBITDA
₹18.26 Cr
Net Profit
₹146.78 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ambalal Sarabhai
| -8.3 | -0.2 | -9.3 | -27.5 | 8.5 | 8.0 | 14.5 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Ambalal Sarabhai
| -49.1 | 34.2 | 41.3 | -20.1 | 51.2 | 27.8 | 16.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ambalal Sarabhai
|
26.2 | 200.8 | 201.6 | 11.1 | 3.7 | 8.8 | 18.2 | 1.3 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 388.9 | 7,603.2 | 1,432.0 | 149.0 | 19.1 | 7.9 | 50.7 | 3.1 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. It operates through Pharmaceuticals and Electronics segments. The company offers products... for oncology, infertility, and uro-gynaec areas under the Sarabhai house name; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio products, and electronic products. Ambalal Sarabhai Enterprises Limited was founded in 1880 and is based in Ahmedabad, India. Read more
Incorporated
1978
Chairman
Kartikeya V Sarabhai
Managing Director
Mohal K Sarabhai
Group
Sarabhai
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Ambalal Sarabhai Enterprises Ltd is ₹26.20 (BSE) and ₹4.25 (NSE) as of 02-Apr-2026 IST. Ambalal Sarabhai Enterprises Ltd has given a return of 8.5% in the last 3 years.
The P/E ratio of Ambalal Sarabhai Enterprises Ltd is 18.20 times as on 02-Apr-2026, a 32 discount to its peers’ median range of 26.59 times.
The P/B ratio of Ambalal Sarabhai Enterprises Ltd is 1.33 times as on 02-Apr-2026, a 70 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
54.47
|
1.92
|
|
2024
|
61.35
|
2.55
|
|
2023
|
13.73
|
1.20
|
|
2022
|
5.66
|
2.23
|
|
2021
|
4.61
|
1.83
|
The 52-week high and low of Ambalal Sarabhai Enterprises Ltd are Rs 42.00 and Rs 23.12 as of 04-Apr-2026.
Ambalal Sarabhai Enterprises Ltd has a market capitalisation of ₹ 201 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Ambalal Sarabhai Enterprises Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.27
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.